expert roundtables

Gauging Seizure Risk in the Treatment of Epilepsy
Neurology

Gauging Seizure Risk in the Treatment of Epilepsy

expert roundtables
By Brian D. Moseley, MD; James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES; John M. Stern, MD
Patient Adherence, More-Forgiving Antiepileptic Drugs, and Potential Impacts
Neurology

Patient Adherence, More-Forgiving Antiepileptic Drugs, and Potential Impacts

expert roundtables
By Brian D. Moseley, MD; James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES; John M. Stern, MD
Non–Tumor Necrosis Factor Biologic Therapies in Rheumatoid Arthritis: The Expanding Evidence Base
Rheumatology

Non–Tumor Necrosis Factor Biologic Therapies in Rheumatoid Arthritis: The Expanding Evidence Base

expert roundtables
By Jeffrey R. Curtis, MD, MS, MPH; Jonathan Kay, MD; Leonard H. Calabrese, DO
Predicting Treatment Response in Patients With Inadequate Responses to Methotrexate
Rheumatology

Predicting Treatment Response in Patients With Inadequate Responses to Methotrexate

expert roundtables
By Jeffrey R. Curtis, MD, MS, MPH; Jonathan Kay, MD; Leonard H. Calabrese, DO
Changing the Natural History of Sickle Cell Disease
Hematology

Changing the Natural History of Sickle Cell Disease

expert roundtables
By Julie Kanter, MD; Michael Rutledge DeBaun, MD, MPH; Stella T. Chou, MD
Load More